Global Anti-venom Market - Snapshot
Biotechnology and healthcare industry is experiencing a significant demand from emerging economies across the globe. The report includes extensive analysis on the historic data across the biotechnology and healthcare segment and forecast for the anti-venom market considering all possible factors impacting the growth. The main factor driving the anti-venom market is the anti-venom treatment being the only standard treatment for snake bite with no alternative treatment. Other factors that support growth of anti-venom market is high prevalence of snake bites, scorpion bites, and other animal or insect bites such as fish stings. Encroachment of forest lands for agricultural and housing purposes has enabled human to be in close proximity to poisonous insects and animals, thus increasing the demand for anti-venom which is most effective treatment for venomous bites.
Developing Nations in MEA and Asia Pacific to Showcase Lucrative Prospects
Continuous research and development to provide innovative drugs and treatment for animal or insect sting has boosted the development of the anti-venom market. High demand for anti-venom Asia Pacific, Middle East & Asia, and Latin America has attracted regional manufacturers for anti-venom development. Increasing demand for anti-venom in developing countries has led to presence of key players in countries like India and Africa, offering anti-venom products at affordable price. The developing global economic conditions create a huge opportunity for the expansion of the anti-venom market. The rise in individual per capita incomes is bound to increase the spending on health care. In the developing countries of Asia Pacific and Middle East, growing population and per capita income are important drivers of the market. According to economist intelligence unit (EIU), the number of high-income households are estimated to be around 540 million by 2019, out of which Asia Pacific is likely to contribute a share of more than 50%.
Region wise global anti-venom market is segmented into five key regions, namely North America (NA), Europe, Asia Pacific (APAC), Latin America (LA), and Middle East & Africa (MEA). Middle East & Africa leads the global anti-venom market followed by Asia Pacific due to presence of highly poisonous snakes in many countries like India, South Africa, Nigeria, etc., which report to have highest death rate due to snake bite. India and South Africa recorded with significant market share in the anti-venom market. India holds dominant position in Asia Pacific anti-venom market accounting to about 50% of the total annual snake bites occurring worldwide, as reported by WHO, thus attracting anti-venom manufacturers in the region.
Polyvalent Segment to Record High Growth
Based on anti-venom type, anti-venom market is segmented into monovalent and polyvalent anti-venom. While based on product type anti-venom market is segmented into snake anti-venom, scorpion anti-venom, spider anti-venom, and other anti-venoms. The market for anti-venom is majorly driven by polyvalent segment. Snake anti-venom segment holds the largest market for anti-venom, owing to high prevalence of venomous snake bites causing high rate of mortality and morbidity without anti-venom treatment. Anti-venom market is further segmented by distribution channel into four main categories i.e. hospitals, clinics, ambulatory surgical centers, and other distribution channels. Segment hospital holds largest share amongst the four in anti-venom market.
High cost of anti-venom owing to high production cost and lack in availability of essential anti-venom stock worldwide is major concern for growth of anti-venom market. Moreover the snake bite health hazard is listed amongst the top neglected tropical disease. Thus, considering this efforts have been taken on national and international level to increase production of anti-venom to gap the supply for anti-venom demand. The anti-venom market is fragmented, with presence of several large industry players. CSL Behring, Bharat Serums and Vaccines Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd, Vacsera, Vins Bioproducts Limited, Rare Therapeutics, etc.
Anti-Venom Market is Gaining Significant Revenues from Agricultural Nations of Asia Pacific
Ceaseless innovative work to give imaginative medications and treatment to creature or creepy crawly sting has supported the advancement of the anti-venom market. Biotechnology and medical services industry is seeing a critical interest from creating economies all around the world. The key factor driving the development of anti-venom market is the interest for anti-venom treatment being the solitary approved treatment for snake chomp with no choice for elective treatment. Infringement of backwoods lands for horticultural and lodging purposes has empowered human to be in close in toxic creepy crawlies and creatures, hence expanding pervasiveness of venomous nibbles. High pervasiveness of scorpion chomps, snake nibbles, and other creature or bug chomps, for example, fish stings are different elements supporting development of anti-venom market.
Biotechnology and medical services industry is encountering a huge interest from arising economies across the globe. The report remembers broad investigation for the memorable information across the biotechnology and medical care portion and figure for the anti-venom market considering all potential elements affecting the development. The primary factor driving the anti-venom market is the anti-venom treatment being the solitary standard treatment for snake nibble with no elective treatment. Different elements that development of anti-venom market is high commonness of snake nibbles, scorpion chomps, and other creature or creepy crawly chomps, for example, fish stings. Infringement of woods lands for agrarian and lodging purposes has empowered human to be in nearness to toxic bugs and creatures, in this way expanding the interest for anti-venom which is best treatment for venomous chomps.
Expanding interest for anti-venom in agricultural nations has prompted presence of vital participants in nations like India and Africa, offering anti-venom items at reasonable cost. The creating worldwide financial conditions set out a gigantic freedom for the extension of the anti-venom market. The ascent in individual per capita wages will undoubtedly build the spending on medical care. In the agricultural nations of Asia Pacific and Middle East, developing populace and per capita pay are significant drivers of the market.
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Anti-venom Market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Anti-Venom Type Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Anti-venom Market Analysis and Forecast, 2016 – 2024
4.4.1. Pricing – Actuals and Projections, 2016-2024 (US$)
4.4.2. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
4.6. Value Chain Analysis
4.7. Market Outlook
Chapter 5. Global Anti-venom Market Analysis and Forecasts, By Anti-Venom Type
5.1. Introduction & Definition
5.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
5.2.1. Monovalent
5.2.2. Polyvalent
5.3. Market Attractiveness By Anti-Venom Type
5.4. Key Trends
Chapter 6. Global Anti-venom Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Market Size (US$ Mn) Forecast By Product Type
6.2.1. Snake Anti-Venom
6.2.2. Scorpion Anti-Venom
6.2.3. Spider Anti-Venom
6.2.4. Others
6.3. Market Attractiveness By Product Type
6.4. Key Trends
Chapter 7. Global Anti-venom Market Analysis and Forecasts, By Distribution Channel
7.1. Introduction & Definition
7.2. Market Size (US$ Mn) Forecast By Distribution Channel
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Ambulatory Surgical centers
7.2.4. Others
7.3. Market Attractiveness By Distribution Channel
7.4. Key Trends
Chapter 8. Global Anti-venom Market Analysis and Forecasts, By Region
8.1. Introduction & Definition
8.2. Market Size (US$ Mn) Forecast By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Europe
8.2.4. Asia Pacific
8.2.5. Middle East and Africa
8.3. Market Attractiveness By Region
8.4. Key Trend
Chapter 9. North America Anti-venom Market Analysis and Forecast
9.1. Introduction
9.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
9.2.1. Monovalent
9.2.2. Polyvalent
9.3. Market Size (US$ Mn) Forecast By Product Type
9.3.1. Snake Anti-Venom
9.3.2. Scorpion Anti-Venom
9.3.3. Spider Anti-Venom
9.3.4. Others
9.4. Market Size (US$ Mn) Forecast By Distribution Channel
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical centers
9.4.4. Others
9.5. Market Size (US$ Mn) Forecast, By Country
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Anti-Venom Type
9.6.2. By Product Type
9.6.3. By Distribution Channel
9.6.4. By Country
9.7. Key Trend
Chapter 10. Europe Anti-venom Market Analysis and Forecast
10.1. Introduction
10.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
10.2.1. Monovalent
10.2.2. Polyvalent
10.3. Market Size (US$ Mn) Forecast By Product Type
10.3.1. Snake Anti-Venom
10.3.2. Scorpion Anti-Venom
10.3.3. Spider Anti-Venom
10.3.4. Others
10.4. Market Size (US$ Mn) Forecast By Distribution Channel
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical centers
10.4.4. Others
10.5. Market Size (US$ Mn) Forecast, By Country
10.5.1. U.K.
10.5.2. France
10.5.3. Germany
10.5.4. Spain
10.5.5. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Anti-Venom Type
10.6.2. By Product Type
10.6.3. By Distribution Channel
10.6.4. By Country
10.7. Key Trend
Chapter 11. Asia Pacific Anti-venom Market Analysis and Forecast
11.1. Introduction
11.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
11.2.1. Monovalent
11.2.2. Polyvalent
11.3. Market Size (US$ Mn) Forecast By Product Type
11.3.1. Snake Anti-Venom
11.3.2. Scorpion Anti-Venom
11.3.3. Spider Anti-Venom
11.3.4. Others
11.4. Market Size (US$ Mn) Forecast By Distribution Channel
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical centers
11.4.4. Others
11.5. Market Size (US$ Mn) Forecast, By Country
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Rest of APAC
11.6. Market Attractiveness Analysis
11.6.1. By Anti-Venom Type
11.6.2. By Product Type
11.6.3. By Distribution Channel
11.6.4. By Country
11.7. Key Trend
Chapter 12. Latin America Anti-venom Market Analysis and Forecast
12.1. Introduction
12.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
12.2.1. Monovalent
12.2.2. Polyvalent
12.3. Market Size (US$ Mn) Forecast By Product Type
12.3.1. Snake Anti-Venom
12.3.2. Scorpion Anti-Venom
12.3.3. Spider Anti-Venom
12.3.4. Others
12.4. Market Size (US$ Mn) Forecast By Distribution Channel
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical centers
12.4.4. Others
12.5. Market Size (US$ Mn) Forecast, By Country
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Anti-Venom Type
12.6.2. By Product Type
12.6.3. BY Distribution Channel
12.6.4. By Country
12.7. Key Trend
Chapter 13. Middle East & Africa Anti-venom Market Analysis and Forecast
13.1. Introduction
13.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
13.2.1. Monovalent
13.2.2. Polyvalent
13.3. Market Size (US$ Mn) Forecast By Product Type
13.3.1. Snake Anti-Venom
13.3.2. Scorpion Anti-Venom
13.3.3. Spider Anti-Venom
13.3.4. Others
13.4. Market Size (US$ Mn) Forecast By Distribution Channel
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical centers
13.4.4. Others
13.5. Market Size (US$ Mn) Forecast, By Country
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. Rest of MEA
13.6. Market Attractiveness Analysis
13.6.1. By Anti-Venom Type
13.6.2. By Product Type
13.6.3. BY Distribution Channel
13.6.4. By Country
13.7. Key Trend
Chapter 14. Competition Landscape
14.1. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.1.1. CSL Behring
14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.1.2. Product Portfolio
14.1.1.3. SWOT Analysis
14.1.1.4. Strategic Overview
14.1.2. Bharat Serums and Vaccines Ltd
14.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.2.2. Product Portfolio
14.1.2.3. SWOT Analysis
14.1.2.4. Strategic Overview
14.1.3. Haffkine Bio-Pharmaceutical Corporation Ltd
14.1.3.1. Company Overview
14.1.3.2. Product Portfolio
14.1.3.3. SWOT Analysis
14.1.3.4. Financial Overview
14.1.3.5. Strategic Overview
14.1.4. Vacsera
14.1.4.1. Company Overview
14.1.4.2. Product Portfolio
14.1.4.3. SWOT Analysis
14.1.4.4. Financial Overview
14.1.4.5. Strategic Overview
14.1.5. Vins Bioproducts Limited
14.1.5.1. Company Overview
14.1.5.2. Product Portfolio
14.1.5.3. SWOT Analysis
14.1.5.4. Financial Overview
14.1.5.5. Strategic Overview
14.1.6. Rare Disease Therapeutics, Inc.
14.1.6.1. Company Overview
14.1.6.2. Product Portfolio
14.1.6.3. SWOT Analysis
14.1.6.4. Financial Overview
14.1.6.5. Strategic Overview
14.1.7. Bharat Biotech
14.1.7.1. Company Overview
14.1.7.2. Product Portfolio
14.1.7.3. SWOT Analysis
14.1.7.4. Financial Overview
14.1.7.5. Strategic Overview
14.1.8. BTG International Ltd.
14.1.8.1. Company Overview
14.1.8.2. Product Portfolio
14.1.8.3. SWOT Analysis
14.1.8.4. Financial Overview
14.1.8.5. Strategic Overview
Chapter 15. Key Takeaways
List of Tables
Table 01: Global Anti-venom Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 02: Global Anti-venom Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 03: Global Anti-venom Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 04: Global Anti-venom Market Size (US$ Mn) Forecast, by Region,
Table 05: Asia Pacific Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 06: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 07: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 08: Asia Pacific Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 09: Middle East & Africa Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 10: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 12: Middle East & Africa Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 13: Latin America Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 14: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 15: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 16: Latin America Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 17: North America Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 18: North America Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 20: North America Anti-venom Market Size (US$ Mn) Forecast, by Country,
Table 21: Europe Market Size (US$ Mn) Forecast, by Anti-Venom Type, 2015–2025
Table 22: Europe Market Size (US$ Mn) Forecast, by Product Type, 2015–2025
Table 23: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 24: Europe Anti-venom Market Size (US$ Mn) Forecast, by Country,
List of Figures
Figure 01: Global Anti-venom Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
Figure 02: Global Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 03: Global Monovalent Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 04: Global Polyvalent Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 05: Global Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 06: Global Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 07: Global Snake Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 08: Global Scorpion Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 09: Global Spider Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 10: Global Other Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 11: Global Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 13: Global Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 14: Global Hospitals Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 15: Global Clinics Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 16: Global Ambulatory Surgical Centers Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 17: Global Other Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 18: Global Anti-Venom Market Attractiveness Analysis, by Distribution Channel
Figure 19: Global Anti-Venom Market Value Share Analysis, by Region, 2017 and 2025
Figure 20: Asia Pacific Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 21: Middle East & Africa Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 22: Latin America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 23: North America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 24: Europe Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 25: Global Anti-Venom Market Attractiveness Analysis, by Region
Figure 26: Asia Pacific Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 27: Asia Pacific Anti-Venom Market Attractiveness Analysis, by Country
Figure 28: Asia Pacific Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 29: Asia Pacific Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 30: Asia Pacific Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 31: Asia Pacific Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 32: Asia Pacific Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 33: Asia Pacific Anti-venom Market Attractiveness Analysis, by Product Type
Figure 34: Asia Pacific Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 35: Asia Pacific Anti-venom Market Attractiveness Analysis, by Country
Figure 36: Middle East & Africa Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 37: Middle East & Africa Anti-Venom Market Attractiveness Analysis, by Country
Figure 38: Middle East & Africa Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 39: Middle East & Africa Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 40: Middle East & Africa Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 41: Middle East & Africa Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 42: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 43: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Product Type
Figure 44: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 45: Middle East & Africa Anti-venom Market Attractiveness Analysis, by Country
Figure 46: Latin America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 47: Latin America Anti-Venom Market Attractiveness Analysis, by Country
Figure 48: Latin America Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 49: Latin America Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 50: Latin America Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 51: Latin America Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 52: Latin America Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 53: Latin America Anti-venom Market Attractiveness Analysis, by Product Type
Figure 54: Latin America Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 55: Latin America Anti-venom Market Attractiveness Analysis, by Country
Figure 56: North America Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 57: North America Anti-Venom Market Attractiveness Analysis, by Country
Figure 58: North America Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 59: North America Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 60: North America Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 61: North America Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 62: North America Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 63: North America Anti-venom Market Attractiveness Analysis, by Product Type
Figure 64: North America Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 65: North America Anti-venom Market Attractiveness Analysis, by Country
Figure 66: Europe Anti-Venom Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
Figure 67: Europe Anti-Venom Market Attractiveness Analysis, by Country
Figure 68: Europe Anti-venom Market Value Share Analysis, by Anti-Venom Type, 2017 and 2025
Figure 69: Europe Anti-venom Market Value Share Analysis, by Product Type, 2017 and 2025
Figure 70: Europe Anti-venom Market Value Share Analysis, by Distribution Channel, 2017 and 2025
Figure 71: Europe Anti-venom Market Value Share Analysis, by Country, 2017 and 2025
Figure 72: Europe Anti-venom Market Attractiveness Analysis, by Anti-Venom Type
Figure 73: Europe Anti-venom Market Attractiveness Analysis, by Product Type
Figure 74: Europe Anti-venom Market Attractiveness Analysis, by Distribution Channel
Figure 75: Europe Anti-venom Market Attractiveness Analysis, by Country
Figure 76: Breakdown of Net Sales (2015), by Segments: CSL Behring
Figure 77: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: CSL Behring
Figure 78: Breakdown of Net Sales (2015), by Segments: Bharat Serums and Vaccines Ltd
Figure 79: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Bharat Serums and Vaccines Ltd
Figure 80: Breakdown of Net Sales (2015), by Segments: Haffkine Bio-Pharmaceutical Corporation Ltd
Figure 81: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Haffkine Bio-Pharmaceutical Corporation Ltd
Figure 82: Breakdown of Net Sales (2015), by Segments: Vacsera
Figure 83: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Vacsera
Figure 84: Breakdown of Net Sales (2015), by Segments: Vins Bioproducts Limited
Figure 85: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Vins Bioproducts Limited
Figure 86: Breakdown of Net Sales (2015), by Segments: Rare Disease Therapeutics, Inc.
Figure 87: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Rare Disease Therapeutics, Inc.
Figure 88: Breakdown of Net Sales (2015), by Segments: Bharat Biotech
Figure 89: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: Bharat Biotech
Figure 90: Breakdown of Net Sales (2015), by Segments: BTG International Ltd.
Figure 91: Revenue (US$ Bn) & Y-o-Y Growth (%), 2012–2015: BTG International Ltd.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Anti-Venom Market
